-
If implemented, recent recommendations from the Department of Health and Human Services Office of Inspector General (OIG) would result in millions of dollars in payment reductions for hospital outpatient departments (HOPDs) and ambulatory surgical centers (ASCs). OIGs report recommends that the Centers for Medicare & Medicaid Services (CMS) set uniform rates for outpatient services provided in ASCs and HOPDs.
-
-
The National Alliance of State and Territorial AIDS Directors and the National Coalition of STD Directors have published a report on STD/HIV integration that provides reasons for integration as well as steps that state and local jurisdictions can take to support integration.
-
As the Infectious Diseases Society of America prepares publication of guidelines for integrating HIV and STD prevention into HIV care settings, health officials are also pushing for better integration between STD and HIV prevention practices.
-
Federal spending for FY2003, which comes more than four months after the fiscal year began, totals $397 million.
-
AIDSVAX, the first AIDS vaccine to complete human trials, showed disappointing results, with only a 3% protection rate. However, researchers were encouraged by preliminary data showing that the antibody response to the vaccine offered protection, particularly in a subgroup of African-Americans and Asians.
-
After more than 15 years of meeting separately, the two committees that advise the U.S. Department of Health and Human Services (HHS) on HIV prevention and care have merged into a single committee, HHS Secretary Tommy Thompson announced recently.
-
The federal governments FY 2003 budget provides modest increases in HIV prevention and care funding, but that additional money wont meet drug treatment needs for the poor or offset significant cuts in state and city health budgets, experts say.
-
AIDSVAX B/B Trial Statistics
-
As several new antiretroviral drugs near Food and Drug Administration approval, treatment strategies are focusing more intensely on the long-term benefits and risks of treatment as patients live longer and face new health problems.